CompanyTrack
E

ELASMOGEN LIMITED

Active Foresterhill

Research and experimental development on biotechnology

17 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
E

ELASMOGEN LIMITED

Research and experimental development on biotechnology

Founded 15 Jan 2014 Active Foresterhill, United Kingdom 17 employees elasmogen.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 7 May 2025
Confirmation Statement Submitted 16 Jan 2025
Net assets £2.81M £1.68M 2024 year on year
Total assets £3.09M £1.89M 2024 year on year
Total Liabilities £282.86K £204.51K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Liberty Building Foresterhill Aberdeen AB25 2ZP

Credit Report

Discover ELASMOGEN LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£2.31M

Decreased by £1.68M (-42%)

Net Assets

£2.81M

Decreased by £1.68M (-37%)

Total Liabilities

£282.86k

Decreased by £204.51k (-42%)

Turnover

N/A

Employees

17

Decreased by 1 (-6%)

Debt Ratio

9%

Decreased by 1 (-10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£1.4m awarded
Show:

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 1,354,526 Shares £10.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Apr 20221,059,771£8.00m£7.549
29 Apr 202235,031£225k£6.416
28 Apr 202120,309£150k£7.37
31 Mar 202138,243£282k£7.37
24 Feb 202120,484£151k£7.37

Officers

Officers

6 active 8 resigned
Status
Andrew Justin Radcliffe PorterDirectorBritishScotland6413 Nov 2015Active
Caroline Jane BarelleDirectorBritishScotland5524 Sept 2015Active
Jane Elizabeth DancerDirectorBritishUnited Kingdom6229 Apr 2022Active
Lucy Edwardes JonesDirectorBritishUnited Kingdom3314 Sept 2023Active
Savvas Ioannou NeophytouDirectorBritishUnited Kingdom535 Apr 2017Active
William Roderick Justin RichardsDirectorBritishUnited Kingdom6730 Aug 2022Active

Shareholders

Shareholders (14)

University Court Of The University Of Aberdeen
12.5%
370,00027 Jan 2023
The University Of Maryland
1.7%
50,00027 Jan 2023
Wcs Nominees Limited
0.3%
8,91327 Jan 2023

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Bgf Investment Management Limited

United Kingdom

Active
Notified 29 Apr 2022
Nature of Control
  • Significant Influence Or Control

Kcp Nominees Ltd

Ceased 29 Apr 2022

Ceased

Caroline Jane Barelle

Ceased 2 Jan 2018

Ceased

Group Structure

Group Structure

BGF INVESTMENT MANAGEMENT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BGF GROUP PLC united kingdom significant influence or control
UBERIOR INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
RBS SME INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
HSBC (BGF) INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BARCLAYS FUNDS INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BARCLAYS EQUITY HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HSBC BANK PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
RBS AA HOLDINGS (UK) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
LBG EQUITY INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BARCLAYS PRINCIPAL INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HSBC HOLDINGS PLC united kingdom
LLOYDS BANKING GROUP PLC united kingdom
NATWEST GROUP PLC united kingdom
BARCLAYS PLC united kingdom
ELASMOGEN LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
7 May 2025AccountsAnnual accounts made up to 2025-01-31View(12 pages)
16 Jan 2025Confirmation StatementConfirmation statement made on 2025-01-15 with updatesView(5 pages)
3 Jul 2024AccountsAnnual accounts made up to 2024-01-31View(12 pages)
22 Jan 2024Confirmation StatementConfirmation statement made on 2024-01-15 with no updatesView(3 pages)
16 Oct 2023OfficersTermination of Keith John Barclay as director on 2023-09-14View(1 page)
7 May 2025 Accounts

Annual accounts made up to 2025-01-31

16 Jan 2025 Confirmation Statement

Confirmation statement made on 2025-01-15 with updates

3 Jul 2024 Accounts

Annual accounts made up to 2024-01-31

22 Jan 2024 Confirmation Statement

Confirmation statement made on 2024-01-15 with no updates

16 Oct 2023 Officers

Termination of Keith John Barclay as director on 2023-09-14

Recent Activity

Latest Activity

Annual accounts made up to 2025-01-31

8 months ago on 7 May 2025

Confirmation statement made on 2025-01-15 with updates

12 months ago on 16 Jan 2025

Annual accounts made up to 2024-01-31

1 years ago on 3 Jul 2024

Confirmation statement made on 2024-01-15 with no updates

1 years ago on 22 Jan 2024

Termination of Keith John Barclay as director on 2023-09-14

2 years ago on 16 Oct 2023